Multiple Sclerosis News Today Forums › Forums › Trials and Research › MS Patient Groups Say Mayzent is Overpriced

  • Trials and Research

    MS Patient Groups Say Mayzent is Overpriced

    Posted by ms-news-today-moderator on April 15, 2019 at 11:20 am

    National organizations that represent MS patients welcome the FDA’s approval of Mayzent (siponimod), but they complain that the therapy is overpriced. Learn more about this controversy here.

    Do you agree that this medication is overpriced? Do you think pharmaceutical companies have a responsibility to price their therapies more affordably?

    replied 5 years ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .